학술논문
Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis
Document Type
Article
Author
Yeh, W.Z.; Widyastuti, P.A.; Van der Walt, A.; Stankovich, J.; Gresle, M.; Butzkueven, H.; Jokubaitis, V.G.; Skibina, O.G.; Havrdova, E.; Horakova, D.; Vodehnalova, K.; Uher, T.; Ozakbas, S.; Eichau, S.; Duquette, P.; Kalincik, T.; Patti, F.; Boz, C.; Terzi, M.; Yamout, B.I.; Lechner-Scott, J.; Sola, P.; Barnett, M.; Onofrj, M.; Sá, M.J.; McCombe, P.A.; Grammond, P.; Ampapa, R.; Grand'Maison, F.; Bergamaschi, R.; Spitaleri, D.L.A.; Van Pesch, V.; Cartechini, E.; Hodgkinson, S.; Soysal, A.; Saiz, A.; Maimone, D.; Turkoglu, R.; Hupperts, R.M.M.; Amato, M.P.; Granella, F.; Oreja-Guevara, C.; Altintas, A.; Macdonell, R.A.; Castillo-Trivino, T.; Alroughani, R.
Source
In: Neurology . (Neurology, 15 June 2021, 96(24):E2989-E3002)
Subject
Language
English
ISSN
1526632X
00283878
00283878